James Rucker – A New Vision for Mental Health

Psychiatry & the psychedelic drugs. Past, present & future

Author: Editorial 19th April 2019 0 Comments

Written by James Rucker, Jonathan Iliff and David Nutt, the abstract of this article (2017, Neuropharmacology) says: “The classical psychedelic drugs, including psilocybin, lysergic acid diethylamide and mescaline, were used extensively in psychiatry before they were placed in Schedule I of the…
Read more

collaborative practice

clinical trials using psychedelics, David Nutt, James Rucker, Jonathan Iliff, lysergic acid diethylamide (LSD), magic mushrooms, mescaline, Neuropharmacology, psilocybin, psychedelic drugs, psychoneurotic

Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential

Author: Editorial 11th February 2019 0 Comments

This article – Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential – appeared in the British Medical Journal (May 2015). It was written by Dr. James Rucker (specialist registrar in adult psychiatry). The article summary…
Read more

a coherent system

James Rucker, LSD, magic mushrooms, psilocybin, psychedelic drugs, Research, UK Misuse of Drugs Act 1971, war on drugs